Company Filing History:
1 out of 86 
1 out of 6 Years Active: 2022
Title: Jan Dallinga: Innovator in Airway Disease Diagnosis
Introduction
Jan Dallinga is a notable inventor based in Maastricht, Netherlands. He has made significant contributions to the field of medical diagnostics, particularly in the area of airway diseases. His innovative approach focuses on the use of volatile organic compounds (VOCs) in exhaled breath to diagnose and monitor airway inflammation.
Latest Patents
Jan Dallinga holds a patent for a method aimed at diagnosing airway disease inflammatory subtypes. The patent, titled "Method for the diagnosis of airway disease inflammatory subtype," encompasses in vitro methods for diagnosing, prognosing, and monitoring neutrophilic or eosinophilic airway inflammation in a subject. This invention includes determining the amount of one or more VOCs in exhaled breath and provides devices for use in these methods. He has 1 patent to his name.
Career Highlights
Throughout his career, Jan Dallinga has worked with esteemed institutions such as the University of Liège and the Centre Hospitalier Universitaire de Liège. His work has been instrumental in advancing the understanding and treatment of airway diseases.
Collaborations
Jan has collaborated with notable colleagues, including Florence Schleich and Renaud Louis. Their combined expertise has contributed to the development of innovative diagnostic methods in the medical field.
Conclusion
Jan Dallinga's work in the diagnosis of airway diseases showcases his commitment to improving healthcare through innovation. His contributions are paving the way for more effective diagnostic tools and treatments in respiratory medicine.